New research by The Worldcom Public Relations Group has ranked pharmaceutical companies according to their usage of digital channels – with Bayer, Pfizer and Boehringer Ingelheim coming out on top.

We found that useful information held by the manufacturing companies is not currently shared in a sufficiently transparent ... Roche Diagnostics, Boehringer Ingelheim, and Lilly through ...

Nerandomilast, an oral phosphodiesterase 4B inhibitor, hit the primary endpoint in a Phase III trial in progressive pulmonary ...

Boehringer Ingelheim says it is on track to launch 25 new treatments in its human pharma division onto the market between now and 2030, fuelled by an R&D pipeline that it says is the best in its ...

ExpressionEdits' Genetic Syntax Engine platform is designed to enhance gene expression within gene therapies by restoring introns.

Boehringer Ingelheim India has signed a Memorandum of Understanding (MoU) with Hyderabad-based EMRI Green Health Services a GVK enterprise, the operator of the Government-funded 108 National Emergency ...

Boehringer Ingelheim said its experimental treatment for a chronic lung disease succeeded in a pivotal study, and it's taking ...

Boehringer Ingelheim has announced a Phase III trial of its investigational lung disease drug nerandomilast has met its primary endpoint. Image credit: Tada Images / Shutterstock Boehringer ...

For more control, third-party tools like TranslucentTB and TaskbarTools let users make the taskbar fully transparent or adjust its transparency level. These apps are easy to use, lightweight, and ...

In view of the extensive global use of such devices, further research is urgently required with reference standards, standardised validation and transparent algorithms. With its rising prevalence and ...